Skip to main content

Table 3 Duration of device usage and causes of reintubation

From: High-flow nasal oxygen cannula vs. noninvasive mechanical ventilation to prevent reintubation in sepsis: a randomized controlled trial

Variables

NIV

(N = 110)

HFNC

(N = 112)

Relative risk

(95% CI)

P

Duration of device usage, median (IQR), h

24 (19–42)

24 (20–55)

 

0.18

Interval from extubation to reintubation, median (IQR), h

67 (23–139)

54 (19–282)

 

0.90

Device protocol compliance rate

105 (95.5)

107 (95.5)

0.99 (0.49–2.01)

0.98

Causes of reintubation, No. (%)

 Hypoxia

21 (19.1)

20 (17.9)

0.96 (0.69–1.34)

0.81

 Hemodynamic instability

6 (5.5)

4 (3.6)

0.82 (0.48–1.38)

0.50

 Cardiac arrest

4 (3.6)

4 (3.6)

0.99 (0.49–2.01)

0.98

 Urgent surgery

2 (1.8)

1 (0.9)

0.74 (0.33–1.67)

0.55

 Inability to clear secretions

1 (0.9)

4 (3.6)

2.51 (0.43–14.57)

0.18

 Altered mental status

1 (0.9)

4 (3.6)

2.51 (0.43–14.57)

0.18

 Others

2 (1.8)

1 (0.9)

0.65 (0.38–1.17)

0.50

  1. Calculated using patients who required reintubation (37 in the NIV group and 33 in the HFNC group)
  2. *Calculated using patients who required a device change (20 in the NIV group and nine in the HFNC group)